MBX Biosciences closes on $115M in drug-development funding - Indianapolis Business Journal

Published on 14 Nov 2022 on Indianapolis Business Journal

Carmel-based MBX Biosciences Inc. said Monday that it has closed on $115 million in funding to help...

Read the rest of the article

Start tracking your investments with Statfolio

After reaching an important support level, Precision BioSciences, Inc. (DTIL) could be a good sto...

Zacks · via Yahoo Finance 18 Apr 2024

Revenues for Q3 2023 were $13.1 million, a significant increase from $7.4 million in Q3 2022.Net ...

GuruFocus.com via Yahoo Finance 7 Nov 2023

Viewing insider transactions for Precision BioSciences, Inc.'s (NASDAQ:DTIL ) over the last year,...

Simply Wall St. via Yahoo Finance 16 Sep 2023

Celebrations may be in order for Precision BioSciences, Inc. (NASDAQ:DTIL) shareholders, with the...

Simply Wall St. via Yahoo Finance 6 Aug 2023

With a price-to-sales (or "P/S") ratio of 3.8x Precision BioSciences, Inc. (NASDAQ:DTIL) may be s...

Simply Wall St. via Yahoo Finance 17 Apr 2023

Insiders were net buyers of Precision BioSciences, Inc.'s (NASDAQ:DTIL ) stock during the past ye...

Simply Wall St. via Yahoo Finance 7 Mar 2023

A new startup founded by scientists out of the Dana-Farber Cancer Institute, among others, is...

The Business Journals 6 Dec 2022

In this article, we discuss the top 15 companies in Alphabet Inc (GOOGL)’s investment portfolio. ...

Insider Monkey via Yahoo Finance 17 Nov 2022

Carmel-based MBX Biosciences Inc. said Monday that it has closed on $115 million in funding to he...

Indianapolis Business Journal 14 Nov 2022

Precision BioSciences (DTIL) came out with a quarterly loss of $0.22 per share versus the Zacks C...

Zacks via Yahoo Finance 8 Nov 2022